A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice.
Yang Y, Jn-Simon N, He Y, Sun C, Zhang P, Hu W, Tian T, Zeng H, Basha S, Huerta AS, Sun LZ, Yin XM, Hromas R, Zheng G, Pi L, Zhou D.
Yang Y, et al. Among authors: zhou d.
Nat Aging. 2025 Jan 31. doi: 10.1038/s43587-025-00811-7. Online ahead of print.
Nat Aging. 2025.
PMID: 39890936